Skip to content

Establishment of a Clinical Staging and Decision-making System for Recurrent Hepatocellular Carcinoma: A Multicenter Retrospective Study

Establishment of a Clinical Staging and Decision-making System for Recurrent Hepatocellular Carcinoma: A Multicenter Retrospective Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400085455
Enrollment
Unknown
Registered
2024-06-07
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent hepatocellular carcinoma

Interventions

Recurrent hepatocellular carcinoma:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Primary liver cancer underwent radical resection for the first time and postoperative pathology confirmed it to be hepatocellular carcinoma; no other treatment methods such as targeted, immune, radiotherapy, chemotherapy, etc. were received before surgery; CT/MRI/liver contrast-enhanced ultrasound and other treatments were used when recurrence Imaging evaluation combined with medical history and tumor markers or pathological biopsy confirmed hepatocellular carcinoma.

Exclusion criteria

Exclusion criteria: Liver metastatic tumors, cholangiocarcinoma, mixed liver cancer and other types of liver malignant tumors; accompanied by a history of other malignant tumors; the patient's clinical pathological data and follow-up data are incomplete or missing.

Design outcomes

Primary

MeasureTime frame
Survival after recurrence;

Secondary

MeasureTime frame
Overall survival;

Countries

China

Contacts

Public Contactwen tianfu

West China Hospital of Sichuan University

wentianfu@scu.edu.cn+86 189 8060 1471

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026